Seonglae ChoEli Lilly drug shown to slow Alzheimer’s progression
Dementia experts hail "watershed moment" after trial results for donanemab antibody treatment.
https://arstechnica.com/health/2023/07/eli-lilly-drug-shown-to-slow-alzheimers-progression/
FDA grants first full approval for an Alzheimer’s drug in 20 years
Questions linger around how many patients will be able to access the drug with limited coverage from Medicare.
https://www.politico.com/news/2023/07/06/fda-grants-approval-alzheimers-drug-00105041
'인류의 적' 치매와 싸울 게임체인저 등장 - 매일경제
알츠하이머 신약 '도나네맙'임상3상서 초기 환자에 효과인지력 저하 속도 35% 늦춰연내 美FDA 승인 받을 듯韓제약사도 치료제 개발 박차
https://www.mk.co.kr/news/society/10787722
